Abstract: The invention provides modulators of indoleamine 2,3-dioxygenase (IDO1) and their use in the prophylaxis and/or treatment of IDO1-mediated diseases. Specifically, the present invention provides compounds according to Formula (I) an enantiomer, diastereomer, tautomer or pharmaceutically acceptable salt thereof.
Type:
Grant
Filed:
November 3, 2017
Date of Patent:
August 3, 2021
Assignee:
Phenex Discovery Verwaltungs-GmbH
Inventors:
Christoph Steeneck, Olaf Kinzel, Simon Anderhub, Martin Hornberger, Gerald Kleymann, Thomas Hoffmann
Abstract: The present invention relates to novel compounds which act as modulators of indoleamine 2,3-dioxygenase (IDO1) and to the use of said compounds in the prophylaxis and/or treatment of diseases or conditions mediated by indoleamine 2,3-dioxygenase. The invention further relates to pharmaceutical compositions comprising the novel compounds.
Type:
Application
Filed:
December 12, 2018
Publication date:
November 12, 2020
Applicant:
PHENEX DISCOVERY VERWALTUNGS-GMBH
Inventors:
Christoph Steeneck, Olaf Kinzel, Simon Anderhub, Martin Hornberger, Marta Czekanska, Thomas Hoffmann
Abstract: The invention provides modulators of indoleamine 2,3-dioxygenase (IDO1) and their use in the prophylaxis and/or treatment of IDO1-mediated diseases. Specifically, the present invention provides compounds according to Formula (I) an enantiomer, diastereomer, tautomer or pharmaceutically acceptable salt thereof.
Type:
Application
Filed:
November 3, 2017
Publication date:
September 26, 2019
Applicant:
PHENEX DISCOVERY VERWALTUNGS-GMBH
Inventors:
Christoph Steeneck, Olaf Kinzel, Simon Anderhub, Martin Hornberger, Gerald Kleymann, Thomas Hoffmann